Ananym Capital Urges Bio-Techne to Explore Potential Sale
Activist investor Ananym Capital Management has acquired a stake in Bio-Techne Corp. The investment firm is advocating for Bio-Techne's board of directors to undertake a strategic review, which would encompass evaluating a potential sale of the company. This move signals increasing pressure from the activist investor on the biotechnology firm's corporate strategy.

Activist investor Ananym Capital Management has established a stake in Bio-Techne Corp. The investment group is now urging Bio-Techne's board to initiate a comprehensive strategic review.
This review, as proposed by Ananym Capital, would include consideration of a potential sale of the company.
According to Bloomberg Markets, Ananym Capital Management is actively pushing for these changes within Bio-Techne Corp.


